The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
Authors
Keywords
FOXA1, Nestin, GATA3, Breast cancer metastases, Immunohistochemistry
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-28
DOI
10.1186/s12885-019-5373-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
- (2018) Séverine Guiu et al. BRITISH JOURNAL OF CANCER
- FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome
- (2018) Willemijne Schrijver et al. Molecular Oncology
- Nestin-positive microvessel density is an independent prognostic factor in breast cancer
- (2017) Aleksandra Nowak et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6
- (2017) Noritaka Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer
- (2017) Kristi Krüger et al. Scientific Reports
- FOXA1 defines cancer cell specificity
- (2016) G. Zhang et al. Science Advances
- FOXA1: a Promising Prognostic Marker in Breast Cancer
- (2014) Qing Hu et al. Asian Pacific Journal of Cancer Prevention
- Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases
- (2014) Y Horimoto et al. BRITISH JOURNAL OF CANCER
- Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer
- (2014) Yuichi Hisamatsu et al. Breast Cancer
- FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer
- (2013) Mai Kawase et al. Breast Cancer
- FOXA1 mutations in hormone-dependent cancers
- (2013) Jessica L. L. Robinson et al. Frontiers in Oncology
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients
- (2012) Nobuhiro Ijichi et al. Hormones & Cancer
- FOXA1 is an independent prognostic marker for ER-positive breast cancer
- (2011) Rutika J. Mehta et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXA1: master of steroid receptor function in cancer
- (2011) Michael A Augello et al. EMBO JOURNAL
- Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
- (2011) F. Piras et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
- (2010) C. M. Robbins et al. GENOME RESEARCH
- FOXA1 in breast cancer
- (2009) Harikrishna Nakshatri et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
- (2009) Foluso O Ademuyiwa et al. MODERN PATHOLOGY
- Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance
- (2008) Hany Onsy Habashy et al. EUROPEAN JOURNAL OF CANCER
- Nestin is expressed in basal-like and triple negative breast cancers
- (2008) S Parry et al. JOURNAL OF CLINICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started